Fundz

Commit Biologics Appoints Thomas L. F. Montgomery Andresen as Chief Executive Officer

PRIVATEMar 11, 2026

Position

Chief Executive Officer

Company

Commit Biologics

Thomas L. F. Montgomery Andresen
AarhusBiotechnologyHealth CareTherapeutics

Description

Commit Biologics announces the appointment of Thomas L. F. Montgomery Andresen, PhD, as Chief Executive Officer

Who to call at Commit Biologics, and when

A new leader at Commit Biologics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Commit Biologics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Commit Biologics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Commit Biologics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Commit Biologics

Location

Aarhus, Central Denmark Region, Denmark

About

Commit Biologics is a company specializing in activating the complement system to treat cancer and autoimmune diseases using their unique Bispecific Complement Engaging (BiCE™) platform.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Commit Biologics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Nick Stub
Likely contact at this company
••••••••@••••••••

See Nick Stub's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Commit Biologics's next move

Learn about Strategic plan

Commit Biologics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.